Details for Patent: 10,143,656
✉ Email this page to a colleague
Which drugs does patent 10,143,656 protect, and when does it expire?
Patent 10,143,656 protects SUTAB and is included in one NDA.
Summary for Patent: 10,143,656
| Title: | Solid oral sulfate salt formulations for cleaning a colon and methods of using same |
| Abstract: | Disclosed herein are solid oral dosage formulations comprising sodium sulfate, magnesium sulfate, and potassium chloride for inducing purgation of the colon of a subject. Furthermore, the disclosed compositions and formulations are useful to cleanse the colon when administered in sufficient quantities. Methods for inducing purgation of the colon and for cleansing the colon are also disclosed. |
| Inventor(s): | Cleveland; Mark vB. (Norwell, MA), Dennett, Jr.; Edmund V. (Walpole, MA), Pelham; Russell W. (Duxbury, MA) |
| Assignee: | |
| Application Number: | 15/669,749 |
|
Patent Claim Types: see list of patent claims | Formulation; Dosage form; |
Drugs Protected by US Patent 10,143,656
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Braintree Labs | SUTAB | magnesium sulfate; potassium chloride; sodium sulfate | TABLET;ORAL | 213135-001 | Nov 10, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
